Dr. Rakesh Patil did his MBBS from prestigious KEM hospital, Mumbai and MD from Nair Hospital, Mumbai and did his DM in medical and peadiatric oncology and Haematology from GCRI (Gujarat Cancer Research Institute), Ahemdabad, an apex regional cancer centre and one of the largest cancer care centre in asia. He has had a glittering academic career, which includes many gold medals. He has a strong inclination for teaching and is well known for his clinics to undergraduate and post graduate students.
He is renowned medical oncologist, having experience of 9 years, mainly practicing in Ghatkopar | Vikhroli | Bhandup | Mulund | Thane | Dombivali. His kin interests are research and advanced medicine. He is principle investigator for multiple national and international trials of targeted therapy and immunotherapy
Dr. Rakesh Patil stood first in his SSC board examination. He was honoured by chief minister and education minister. He completed his MBBS from prestigious KEM hospital, Mumbai (no.1 medical institute in Maharashtra). He has done MD medicine from Nair Hospital (no.3 medical institute in Maharashtra). He did his DM in medical and paediatric oncology and hemato – oncology from Gujrat Cancer Research Institute (GCRI), Ahemdabad; an apex regional cancer centre and one of the largest cancer care centre in Asia. He has had a glittering academic career, which includes distinctions in multiple subjects and gold medals. He has done his whole 15 year medical journey only in topmost Govt / BMC hospitals which helped him to sharpen his clinical skills. His entire education was on merit basis and funded by government scholarships and TATA scholarships.
He has got vast clinical experience because of studying in topmost Govt / BMC medical hospitals. He is currently seeing 800+ patients per month and giving 5000+ chemotherapy per year. His mentor, well known oncologist Dr. Sonia Parikh madam had taught him that giving chemotherapy is easy but managing its after effects are difficult. Because of vast experience, he often diagnose complications early, so that serious side effects are minimal. He has a firm belief that medical oncology is at the verge of transformation, so he has specialized in research, targeted therapy and immunotherapy. He is currently principle investigator for multiple clinical trials (including international) for study of newer molecular agents.
Committment to provide Excellent Oncology & Hematology healthcare services.